135 related articles for article (PubMed ID: 8674274)
1. Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas.
Volm M; Koomagi R; Kaufmann M; Mattern J; Stammler G
Clin Exp Metastasis; 1996 May; 14(3):209-14. PubMed ID: 8674274
[TBL] [Abstract][Full Text] [Related]
2. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
3. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
4. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.
Volm M; van Kaick G; Mattern J
Clin Exp Metastasis; 1994 Jul; 12(4):329-34. PubMed ID: 7913670
[TBL] [Abstract][Full Text] [Related]
5. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
6. Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases.
Volm M; Drings P; Wodrich W; van Kaick G
Clin Exp Metastasis; 1993 Jul; 11(4):325-9. PubMed ID: 8100491
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
Sato S; Ito K; Ozawa N; Yajima A; Sasano H
Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
[TBL] [Abstract][Full Text] [Related]
8. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of oncogenes and growth factors in ovarian carcinomas.
Bauknecht T; Birmelin G; Kommoss F
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):855-62. PubMed ID: 2285597
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
Volm M
Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
[TBL] [Abstract][Full Text] [Related]
11. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer.
Ikeda K; Sakai K; Yamamoto R; Hareyama H; Tsumura N; Watari H; Shimizu M; Minakami H; Sakuragi N
Int J Gynecol Cancer; 2003; 13(6):776-84. PubMed ID: 14675314
[TBL] [Abstract][Full Text] [Related]
13. Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypes.
Bauknecht T; Angel P; Kohler M; Kommoss F; Birmelin G; Pfleiderer A; Wagner E
Cancer; 1993 Jan; 71(2):419-29. PubMed ID: 8422634
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.
Volm M; Drings P; Wodrich W
J Cancer Res Clin Oncol; 1993; 119(9):507-10. PubMed ID: 8100821
[TBL] [Abstract][Full Text] [Related]
15. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of resistance-related proteins in human lung tumors with poor vascularization.
Koomägi R; Mattern J; Volm M
Carcinogenesis; 1995 Sep; 16(9):2129-33. PubMed ID: 7554065
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of the expression of drug-resistant proteins in large cell neuroendocrine carcinoma of the lung.
Okada D; Kawamoto M; Koizumi K; Tanaka S; Fukuda Y
Jpn J Thorac Cardiovasc Surg; 2003 Jul; 51(7):272-6. PubMed ID: 12892456
[TBL] [Abstract][Full Text] [Related]
18. Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas.
Koomägi R; Mattern J; Volm M
Anticancer Res; 1999; 19(5B):4333-6. PubMed ID: 10628396
[TBL] [Abstract][Full Text] [Related]
19. Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin.
Masanek U; Stammler G; Volm M
Anticancer Drugs; 1997 Feb; 8(2):189-98. PubMed ID: 9073315
[TBL] [Abstract][Full Text] [Related]
20. Oncogene and growth factor expression in ovarian cancer.
Kommoss F; Bauknecht T; Birmelin G; Kohler M; Tesch H; Pfleiderer A
Acta Obstet Gynecol Scand Suppl; 1992; 155():19-24. PubMed ID: 1502888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
